Author: healthylife7

Although each rare disease affects only a small number of people, collectively they represent one of the world’s largest unmet healthcare challenges. More than 7,000-8,000 rare diseases have been identified globally, yet effective treatments exist for only around 5-10 per cent of them, according to IQVIA. Together, these conditions affect an estimated 350-475 million people…

Read More

Brazil’s health regulator, Anvisa, approved the registration of five new semaglutide injection pens on Wednesday (29). The decision marks the entry of Brazilian pharmaceutical company Hypera, Switzerland’s Sandoz, and India’s Sun Pharma into the market for the molecule used in weight-loss pens made by Denmark’s Novo Nordisk, the manufacturer of Ozempic and Wegovy. Brazil has…

Read More

Transgender and gender diverse (TGD) individuals experience significant healthcare disparities across the oncology spectrum of care. Systemic barriers, past harmful healthcare experiences and sociopolitical climate, and other impediments to accessing health care among others, combine to influence these disparities. TGD individuals undergoing gender-affirming mastectomy (‘top surgery’) face unique challenges related to breast cancer risk assessment…

Read More